GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Market Cap

Devyser Diagnostics AB (OSTO:DVYSR) Market Cap : kr2,014.2 Mil (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Devyser Diagnostics AB's share price for the quarter that ended in Sep. 2024 was kr127. Devyser Diagnostics AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 16.5 Mil. Therefore, Devyser Diagnostics AB's market cap for the quarter that ended in Sep. 2024 was kr2,093.5 Mil.

Devyser Diagnostics AB's quarterly market cap increased from Mar. 2024 (kr1,652.9 Mil) to Jun. 2024 (kr1,860.4 Mil) and increased from Jun. 2024 (kr1,860.4 Mil) to Sep. 2024 (kr2,093.5 Mil).

Devyser Diagnostics AB's annual market cap declined from Dec. 2021 (kr1,345.7 Mil) to Dec. 2022 (kr1,160.8 Mil) but then increased from Dec. 2022 (kr1,160.8 Mil) to Dec. 2023 (kr1,280.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Devyser Diagnostics AB's Enterprise Value for Today is kr1,904.0 Mil.


Devyser Diagnostics AB Market Cap Historical Data

The historical data trend for Devyser Diagnostics AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Market Cap Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - 1,345.67 1,160.82 1,279.96

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,061.75 1,279.96 1,652.88 1,860.36 2,093.51

Competitive Comparison of Devyser Diagnostics AB's Market Cap

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Market Cap falls into.



Devyser Diagnostics AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Devyser Diagnostics AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr78.6*16.2845
=kr1,280.0

Devyser Diagnostics AB's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=kr127*16.4843
=kr2,093.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devyser Diagnostics AB  (OSTO:DVYSR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Devyser Diagnostics AB Market Cap Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Devyser Diagnostics AB Business Description

Traded in Other Exchanges
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines